Upgrading Cell Therapies for Cancer Treatment

This webinar will be hosted live and available on-demand

Friday, November 15th, 2024
11:30 AM - 12:30 PM ET 

Cell-based treatments such as CAR T cell therapy have potent anticancer effects. However, researchers developing these therapies have several hurdles to overcome, including therapy resistance, side effects, and reduced efficacy in solid tumors. 

In this webinar brought to you by The Scientist, researchers will discuss their efforts to uncover mechanistic challenges and molecular insights that improve cell therapy discovery and development.

Topics to be covered

• CAR T cell therapy challenges in acute myeloid leukemia (AML), including the complexity of target antigen selection
• Novel CAR T cell therapy approaches
• Ex vivo and in vivo CRISPR editing to reprogram T cells
• Using CRISPR to discover new gene circuits, add synthetic receptors and transcriptional programs, and manufacture next-generation CAR T cells

Paulina Velasquez, MD  Associate Member  Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children’s Research Hospital

Justin Eyquem, PhD Assistant Professor UCSF-Gladstone Institute for Genomic Immunology Department of Medicine, Hematology & Oncology University of California, San Francisco